CN108410786A - 高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法 - Google Patents
高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法 Download PDFInfo
- Publication number
- CN108410786A CN108410786A CN201810140886.8A CN201810140886A CN108410786A CN 108410786 A CN108410786 A CN 108410786A CN 201810140886 A CN201810140886 A CN 201810140886A CN 108410786 A CN108410786 A CN 108410786A
- Authority
- CN
- China
- Prior art keywords
- gene
- bacillus subtilis
- dna
- fibrinolysin
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 45
- 244000063299 Bacillus subtilis Species 0.000 title claims abstract description 39
- 241000894006 Bacteria Species 0.000 title claims abstract description 38
- 108010088842 Fibrinolysin Proteins 0.000 title claims abstract description 30
- 229940001501 fibrinolysin Drugs 0.000 title claims abstract description 27
- 230000014509 gene expression Effects 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000003209 gene knockout Methods 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 239000013612 plasmid Substances 0.000 claims description 10
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 7
- 101100059011 Bacillus subtilis (strain 168) capB gene Proteins 0.000 claims description 6
- 101150103033 lpxB gene Proteins 0.000 claims description 6
- 238000012795 verification Methods 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- 101100449690 Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / CCUG 7422 / NBRC 12200 / NCIMB 9375 / NCTC 10341 / NRRL NRS-1264 / Gibson 46) blaSE gene Proteins 0.000 claims description 5
- 101100109159 Bacillus subtilis (strain 168) aprX gene Proteins 0.000 claims description 5
- 101100043757 Bacillus subtilis (strain 168) bpr gene Proteins 0.000 claims description 5
- 101100043755 Bacillus subtilis (strain 168) epr gene Proteins 0.000 claims description 5
- 101100238373 Bacillus subtilis (strain 168) mpr gene Proteins 0.000 claims description 5
- 101100049732 Bacillus subtilis (strain 168) wprA gene Proteins 0.000 claims description 5
- 101100381938 Dichelobacter nodosus bprV gene Proteins 0.000 claims description 5
- 101710149136 Protein Vpr Proteins 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000004382 Amylase Substances 0.000 claims description 4
- 102000013142 Amylases Human genes 0.000 claims description 4
- 108010065511 Amylases Proteins 0.000 claims description 4
- 235000019418 amylase Nutrition 0.000 claims description 4
- 230000002068 genetic effect Effects 0.000 claims description 4
- 101150042065 spo0A gene Proteins 0.000 claims description 4
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 229920002643 polyglutamic acid Polymers 0.000 claims description 3
- 230000028070 sporulation Effects 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- 101150106774 9 gene Proteins 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims description 2
- 238000013467 fragmentation Methods 0.000 claims description 2
- 238000006062 fragmentation reaction Methods 0.000 claims description 2
- 238000012772 sequence design Methods 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000000855 fermentation Methods 0.000 description 13
- 230000004151 fermentation Effects 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000005611 electricity Effects 0.000 description 6
- 239000003527 fibrinolytic agent Substances 0.000 description 6
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000003480 fibrinolytic effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000013557 nattō Nutrition 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 description 3
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000002537 thrombolytic effect Effects 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000726221 Gemma Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 229940086319 nattokinase Drugs 0.000 description 2
- 108010073682 nattokinase Proteins 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229940012957 plasmin Drugs 0.000 description 2
- 230000033885 plasminogen activation Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 229960005356 urokinase Drugs 0.000 description 2
- OJHZNMVJJKMFGX-RNWHKREASA-N (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.O=C([C@@H]1O2)CC[C@H]3[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 OJHZNMVJJKMFGX-RNWHKREASA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 101710089384 Extracellular protease Proteins 0.000 description 1
- 108010058861 Fibrin Fibrinogen Degradation Products Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000012335 Plasminogen Activator Inhibitor 1 Human genes 0.000 description 1
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000831652 Salinivibrio sharmensis Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 101150076516 aprN gene Proteins 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000208 fibrin degradation product Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 108700022290 poly(gamma-glutamic acid) Proteins 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 108010073863 saruplase Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21062—Subtilisin (3.4.21.62)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法。本发明通过基因敲除技术，改造现有的枯草芽孢杆菌菌种，得到了一种高效表达纤溶酶的枯草芽孢杆菌工程菌。该方法路线清晰，简单有效，可以运用于多种枯草芽孢杆菌，具有较好的实用性。
Description
技术领域
本发明涉及生物技术领域，具体是指一种高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法。
背景技术
纤溶酶是能专一降解纤维蛋白凝胶的蛋白水解酶，具有溶解血栓，降低血粘度，改善血液循环，软化和增加血管弹性等作用。近年来，纳豆激酶(nattokinase，简称NK)作为一种高效安全的新型纤溶酶，正在成为当今溶栓药研究的焦点。
该酶是在纳豆发酵过程中由纳豆枯草杆菌产生的一种丝氨酸蛋白酶，自1995年我国第一篇有关纳豆和纤溶酶的报道以来，至今已有多篇相关文章发表，目前纤溶酶的溶栓机制已阐明，包括①直接溶栓作用，激活交联纤维蛋白，降解为纤维蛋白降解物；②刺激血管内皮细胞产生组织型纤溶酶原激活剂(t-PA)，t-PA将纤溶酶原激活为纤溶酶，溶解纤维蛋白；③将人体内的尿激酶原激活为尿激酶，尿激酶与t-PA共同激活纤溶酶原，产生纤溶酶溶解血栓；④通过降解和失活纤溶酶原激活剂的抑制剂(PAI-1)调控纤溶作用。此外，纤溶酶在体内外溶栓的动物试验、急性毒性试验及治疗脑梗塞的初步临床试验等方面的大量研究工作已部分完成或正在进行中。
纤溶酶的主要生产菌株——纳豆芽孢杆菌，是枯草芽孢杆菌的一种，是一类好氧型、内生抗逆孢子的革兰氏阳性细菌，能分泌大量的蛋白到胞外，其研究历史已经有40多年，遗传背景清楚，其表达系统已成为继大肠杆菌表达系统之后最重要的原核表达系统，优势在于：①没有毒性；②蛋白分泌表达量高；③密码子使用偏好性不大；④基础研究、基因操作技术和发酵技术成熟。
纤溶酶传统发酵方式是固体发酵，但该方式提纯困难，回收率低，难以满足工业化放大生产的要求，因此，近年来关于纤溶酶产量的研究更倾向于液体发酵方式。目前，纤溶酶生产菌株主要以筛选方式获得，发明专利申请CN105238720A和CN101979531A等多篇专利申请和发表文章均通过筛选获得高产纤溶酶菌株，发明专利申请CN105368762A通过菌株改造得到高效分泌纤溶酶工程菌株，但是，前者只通过筛选而未进行改造，后者只经过菌株改造而所用菌株并非纤溶酶高产菌，所以在纤溶酶产量及酶活方面，两者均没有明显优势。
发明内容
本发明的目的是为了克服现有高产纤溶酶菌株在纤溶酶产量及酶活方面的缺陷，提供一种高效表达纤溶酶的枯草芽孢杆菌工程菌及其制备方法。
为实现上述目的，首先，本发明提供一种高效表达纤溶酶的枯草芽孢杆菌工程菌，其特征在于：它是通过将枯草芽孢杆菌进行基因敲除后获得；所敲除的基因包括芽孢形成编码基因spo0A，淀粉酶编码基因amyE，部分蛋白酶编码基因bpr、mpr、epr、vpr、wprA、aprX，聚谷氨酸合酶编码基因pgsB。
上述方案中，采用的枯草芽孢杆菌为枯草芽孢杆菌枯草亚种，其保藏编号为CICC20637。
本发明还提供了上述高效表达纤溶酶的枯草芽孢杆菌工程菌的制备方法，包括如下步骤：
1)根据目标基因上下游同源臂序列设计敲除引物，引物末端和载体末端具有15～20个同源碱基；
2)PCR扩增：提取枯草芽孢杆菌总DNA，以其作为模板，用各基因对应的上、下游同源臂引物进行PCR扩增，得到目的同源臂DNA片段；
3)通过SOE-PCR分别将各基因的上下游同源臂连接起来，得到9个基因敲除片段；
4)通过无缝克隆将基因敲除片段连接到敲除载体上，得到对应的9个目标基因敲除载体；
5)枯草芽孢杆菌的遗传转化，对枯草芽孢杆菌感受态的制备及利用1个目标基因敲除载体进行电转化；
6)通过抗性筛选和PCR扩增对转化子进行验证；
7)挑选阳性转化子进行传代，经过高温传代，质粒消除，点种和PCR验证后，筛选出目标基因敲除菌株；
8)在得到目标基因敲除菌株后，以其为出发菌株，重复步骤5)～7)用同样的方法对下一个目标基因进行敲除，直至得到敲除9个基因的目标菌种。
步骤4)中所述敲除载体是参考文献(张周刚，宋亚囝，姜凯等.嗜碱芽孢杆菌N16-5木寡糖结合蛋白XynE的功能表征[J].微生物学报，2015，55(1)：40-49)对质粒pE194和pHY300PLK进行改造组合后得到的枯草芽孢杆菌温敏型敲除载体pHY194。
步骤5)中所述的遗传转化方法是按照参考文献(Xue GP,Johnson JS,
Dalrymple BP.High osmolarity improves the electro-transformationefficiency of thegram-positive bacteria Bacillus subtilis and Bacilluslicheniformis.J Microbiol Method,1999,34:183-191)中描述的方法。
步骤7)中所述的质粒消除是指高温培养菌株进行传代，由于敲除载体在枯草芽孢杆菌中的复制子是温敏型复制子，所以在高温条件下质粒会丢失，再通过PCR进行验证。
步骤8)中所述为基因叠加敲除，使目标基因敲除后的效果叠加。
本发明原理：
基于纤溶酶良好的应用前景和枯草芽孢杆菌成熟的表达系统，本发明对高产纤溶酶的枯草芽孢杆菌进行了以下改造：
①除了芽孢形成编码基因spo0A，使菌体生长至稳定前期时不形成芽孢，延长有效发酵时间，提高目标蛋白的表达量；
②敲除了淀粉酶编码基因amyE，发酵条件下，枯草芽孢杆菌淀粉酶表达量较高，减低了原料的转化率，当不以淀粉作为碳源时，将其编码基因敲除，可提高原料的转化率；
③敲除了蛋白酶编码基因(bpr,mpr,epr,vpr,wprA和aprX)，纤溶酶属于丝氨酸蛋白酶，由aprN基因编码，减少菌株其他分泌蛋白酶的表达，可提高原料的利用率；
④敲除了聚谷氨酸合酶编码基因pgsB，聚谷氨酸γ-PGA是一种粘性物质，是纳豆发酵过程中的副产物之一，对其进行敲除，可以提高原料利用率，此外，由于其粘度大，液体发酵时会造成发酵液溶氧浓度不足，影响菌株生长及目标蛋白的积累，对基因pgsB进行敲除，能够提高发酵效率，整体上能够提高胞外蛋白酶的总表达量。
本发明的有益效果：通过基因敲除技术，改造现有的枯草芽孢杆菌菌种，得到了一种高效表达纤溶酶的枯草芽孢杆菌工程菌。该方法路线清晰，简单有效，可以运用于多种枯草芽孢杆菌，具有较好的实用性。
附图说明
图1为基因敲除载体的构建示意图。
图2为枯草芽孢杆菌的基因敲除流程示意图。
具体实施方式
以下结合附图和具体实施例对本发明作进一步详细描述，实施例仅为举例，不用于限制本发明。
下述实施例中所使用的培养基的配方如下：
LB培养基：蛋白胨10g/L，酵母抽提物5g/L，氯化钠10g/L，pH 7.2-7.4；固体培养基加琼脂粉15g/L。
芽孢杆菌电转感受态制备培养基：生长培养基：含0.5mol/L山梨醇的LB培养基；洗涤培养基：10％甘油，0.5mol/L山梨醇，0.5mol/L甘露醇；恢复培养基：含0.5mol/L山梨醇，0.38mol/L甘露醇的LB培养基。
液体种子培养基：大豆蛋白胨1％，牛肉膏0.5％，葡萄糖1％，NaCl 0.75％，pH7.2。
液体发酵培养基：蛋白胨2％，葡萄糖2％，CaCl2 0.02％、MgSO4 0.02％、K2HPO40.1％、KH2PO4 0.1％、KH2PO4 0.1％，pH7.2。
下述实施例中的实验材料，如无特殊说明，均可以通过常规的商业途径购得。下述实施例中所采用的方法，如无特殊说明，均为常规方法。
实施例1
9种敲除载体的构建
枯草芽孢杆菌菌种(B.subtilis)来源于中国工业微生物菌种保藏管理中心(CICC)，保藏编号No.20637。
(1)枯草芽孢杆菌基因组DNA小提：挑取B.subtilis单菌落于5ml LB液体培养基中，37℃振荡培养过夜，12000r/min离心5min收集菌体；STE洗涤菌体1次；加入200μlSolution I溶液和20μl 100mg/ml溶菌酶，重悬菌体，置于37℃下作用2-3h或置于4℃冰箱过夜；加入200μl 10％SDS，50-60℃水浴30min至澄清；加入100μl或200μl 5mol/L NaCl，混匀后12000r/min离心5min，取上清至干净离心管；等体积苯酚/氯仿抽提2次，取上清至干净离心管中；加入2倍体积的无水乙醇置于-20℃沉淀2h，12000r/min离心5min，弃上清；70％乙醇洗涤1次，乙醇晾干后溶于30-60μl的RNase(20μg/ml)，37℃作用30min后置于-20℃保存。
(2)敲除载体上下游同源臂的PCR扩增：普通PCR反应：反应条件：95℃5min；95℃30s，55℃30s，72℃2min，30个循环；72℃延伸10min；4℃保温(其中退火温度根据引物的Tm值进行调整，延伸时间根据扩增目的片段的大小进行调整)。
按下列反应体系依次加入到PCR管中，混匀并离心后置于PCR仪上进行PCR反应。
SOE-PCR反应条件：95℃5min；95℃30s，55℃30s，72℃2min，7个循环；72℃延伸10min(不加引物)；在反应体系中加入引物进行以下反应程序：95℃30s，58℃30s，72℃2min，30个循环；72℃延伸10min；4℃保温(其中退火温度根据引物的Tm值进行调整，延伸时间根据扩增目的片段的大小进行调整)。
按下列反应体系依次加入(引物暂不加入)到PCR管中，混匀并离心后置于PCR仪上进行PCR反应。
DNA体外重组方法：DNA的回收纯化、无缝克隆等操作参照相应产品供应商提供的方法或操作说明。
(3)敲除载体构建
大肠杆菌感受态细胞的制备：挑取大肠杆菌DH5α单菌落于37℃，180r/min振荡培养过夜；1％接种量接种于50ml LB，37℃，180r/min振荡培养2-4h，待细菌长至对数生长期(OD600为0.5-0.6)；将菌液在冰上预冷10min后，倒入50ml预冷的离心管中，4℃5000r/min离心5min，收集菌体；用10ml预冷的CaCl2(0.1mol/L)重悬菌体，冰上放置30min后，4℃5000r/min离心5min，用1ml预冷的CaCl2溶液重悬菌体，并于4℃保存于12-24h内可用于转化；感受态细胞也可由170μl菌悬液与30μl无菌甘油混匀，分装于无菌1.5ml离心管中，置于-70℃保存备用。
大肠杆菌感受态细胞的钙转：取100-200μl感受态细胞与一定量的无缝克隆产物混合，冰上静置15-30min；随后置于42℃水浴锅中热击90s；快速置于冰中，使细胞冷却2-5min；每管加入800μl LB液体培养基，37℃，120r/min恢复培养45min；取200μl菌液涂布于含相应抗生素的LB固体培养基上；固体培养基置于37℃培养箱，静置培养12-16h后，可长出单菌落。
转化子验证：用灭菌的牙签挑少量的转化子菌落于装有预混好的eazyTaq PCR体系中，搅拌使菌体充分混匀，进行PCR扩增反应(PCR预变性时间延长为10min，以裂解大肠杆菌细胞)。取PCR产物进行琼脂糖凝胶电泳检测。经过菌落PCR初步确定为阳性转化子后，提取转化子质粒，提取的质粒用于PCR及酶切验证。
将PCR鉴定结果为阳性的转化子进行测序分析，经过测序鉴定，得到的敲除载体序列正确，将敲除载体分别命名为pHY194Δspo0A，pHY194ΔamyE，pHY194Δbpr，pHY194Δmpr，pHY194Δepr，pHY194Δvpr，pHY194ΔwprA，pHY194ΔaprX，pHY194ΔpgsB。
实施例2
枯草芽孢杆菌的基因敲除
(1)枯草芽孢杆菌感受态的制备：挑取B.subtilis单菌落于5ml LB培养基，37℃振荡培养过夜；种子液以5％的接种量转接至50ml B.subtilis电转生长培养基中，37℃，250r/min振荡培养2-3h至OD600为0.85-0.95，将菌液冰浴10min；5000r/min离心5min收集菌体，用B.subtilis电转洗涤培养基洗涤菌体4次，最后用1ml洗涤培养基重悬细胞，分装至1.5ml离心管中，每管100μl于-80℃保存，即感受态细胞，以上步骤均在冰上操作。
(2)电转化：取一管感受态细胞加入5-10μl质粒DNA(单个敲除载体)，轻轻混匀后转至预冷的电转杯(0.2cm)中，冰浴1-2min，用电脉冲转化仪2.5kV电击1次，电击完后迅速加0.9ml B.subtilis电转恢复培养基，37℃，100r/min恢复培养3h，涂布含有相应抗生素的LB固体培养基上，37℃静置培养过夜，筛选转化子。
(3)转化子验证：经过菌落PCR初步确定为阳性转化子后，提取转化子质粒，提取的质粒用于PCR及酶切验证。
(4)单交换菌株的获得：挑取含有温敏型敲除载体的B.subtilis阳性转化子菌落在LB固体培养基(20μg/ml Tet)上划线，45℃培养12h；挑单菌落于5ml液体LB培养基(20μg/ml Tet)，45℃，培养12h；菌液在LB固体培养基(20μg/ml Tet)上划线，45℃培养12h，长出的单菌落进行菌落PCR验证，验证正确的即为单交换菌株。
(5)基因敲除菌株的获得和鉴定：单交换菌株在5ml无抗性液体LB培养基中传代培养6代，37℃，每代12h；每次接种前一代培养物10μl于5ml无抗性液体LB培养基。最后一代培养物稀释(10-6-10-7)，涂布LB固体培养基，37℃培养至长出单菌落，挑单菌落点种于含Tet的LB固体培养基和不含Tet的LB固体培养基上。对在不含Tet的LB固体培养基上生长而在含Tet的LB固体培养基上不长的单菌落进行菌落PCR鉴定，初步确定为双交换菌株后，提取基因组DNA，PCR验证，并将PCR产物进行测序鉴定。
(6)测序正确的菌株即为基因敲除菌株，在得到目标基因敲除菌株后，以其为出发菌株，用同样的方法对下一个目标基因进行敲除，最终得到敲除菌株B.subtilis 20637Δspo0AΔamyEΔbprΔmprΔeprΔvprΔwprAΔaprXΔpgsB(简称B.subtilis 20637Δ9)。
实施例3
工程菌株发酵及纤溶酶活性检测
(1)菌种活化：挑取甘油管保藏的B.subtilis 20637和B.subtilis 20637Δ9菌株于LB平板上划线，37℃培养12h，挑取单菌落再在LB平板上划线，37℃培养12h；
(2)种子培养：从LB固体培养基上挑取单菌落接种至50ml液体种子培养基，转速为220r/min，37℃振荡培养12h，作为发酵种子液；
(3)发酵培养：采用3L发酵罐，装液体积为1.5L，接种量为2％，发酵温度设定为37℃。搅拌转速800r/min，通气量2L/min，pH控制在6.8-7.2，发酵48h。
(4)纤溶酶酶活检测：参考专利CN103937830B，具体操作如下：①吸取发酵液1ml于离心管中，10000r/min离心10分钟，吸取上清液于试管中备用；②在另一支试管中加入50mmol/L硼砂缓冲液1.4ml及纤维蛋白原溶液0.4ml，在37℃的恒温水浴锅中加热5分钟后，加入凝血酶0.1ml，混匀。③37℃水浴中保温10分钟，再加入0.1ml样品溶液，混匀5秒钟，保温60分钟，在保温第20分钟及第40分钟时，分别取出振荡。④保温结束后，往试管中加入200mmol/L三氯乙酸2ml，再放入水浴锅保温20分钟，15000r/min离心5分钟。⑤取上清液在275nm处测定吸光值。加入相同量的灭活的酶液作空白对照，空白对照的处理方法与样品的处理方法一样。⑥每组均设3个平行样品，最终测定结果为3个测定值的平均值。
(5)检测结果如表1
表1工程菌株的纤溶酶酶活
序列表：基因敲除引物
序列表
<110> 武汉瑞法医疗器械有限公司
<120> 高效表达纤溶酶的枯草芽孢杆菌工程菌
<130> 2018
<160> 56
<170> SIPOSequenceListing 1.0
<210> 1
<211> 25
<212> DNA
<213> plas-F
<400> 1
gtgctgtttt atcctttacc ttgtc 25
<210> 2
<211> 20
<212> DNA
<213> plas-R
<400> 2
tgctgaaagg tgcgttgaag 20
<210> 3
<211> 39
<212> DNA
<213> spo0A-AF
<400> 3
caacgcacct ttcagcagaa acaggaggca tcgtacagg 39
<210> 4
<211> 45
<212> DNA
<213> spo0A-AR
<400> 4
gctctaacct cagcttatcc gccgattatc atcagcaaca caaac 45
<210> 5
<211> 45
<212> DNA
<213> spo0A-BF
<400> 5
gtttgtgttg ctgatgataa tcggcggata agctgaggtt agagc 45
<210> 6
<211> 43
<212> DNA
<213> spo0A-BR
<400> 6
gtaaaggata aaacagcacg gtgccttata aagattaatg tgc 43
<210> 7
<211> 23
<212> DNA
<213> spo0A-yanF
<400> 7
ttctaccgaa gtcaaaaaag ggc 23
<210> 8
<211> 22
<212> DNA
<213> spo0A-yanR
<400> 8
tctagttgac cctaactgga cg 22
<210> 9
<211> 38
<212> DNA
<213> amyE-AF
<400> 9
caacgcacct ttcagcagct catgccgaga atagacac 38
<210> 10
<211> 43
<212> DNA
<213> amyE-AR
<400> 10
gccctcaatg gggaagagaa cgcagtaaag aggttttgaa tcg 43
<210> 11
<211> 43
<212> DNA
<213> amyE-BF
<400> 11
cgattcaaaa cctctttact gcgttctctt ccccattgag ggc 43
<210> 12
<211> 41
<212> DNA
<213> amyE-BR
<400> 12
gtaaaggata aaacagcacg ctcgccatga cttcactaac g 41
<210> 13
<211> 20
<212> DNA
<213> amyE-yanF
<400> 13
ttgcgctgct tgatgtgatc 20
<210> 14
<211> 23
<212> DNA
<213> amyE-yanR
<400> 14
catgttgcgt aagtcaggat atc 23
<210> 15
<211> 39
<212> DNA
<213> pgsB-AF
<400> 15
caacgcacct ttcagcattc ggactcgtat gtttagcgt 39
<210> 16
<211> 45
<212> DNA
<213> pgsB-AR
<400> 16
ctgctttacc ttgtattcgt gggatgacca gtatgacagc acagg 45
<210> 17
<211> 45
<212> DNA
<213> pgsB-BF
<400> 17
cctgtgctgt catactggtc atcccacgaa tacaaggtaa agcag 45
<210> 18
<211> 41
<212> DNA
<213> pgsB-BR
<400> 18
gtaaaggata aaacagcact tcatcgtttg acacacctta c 41
<210> 19
<211> 23
<212> DNA
<213> pgsB-yanF
<400> 19
tgacaaagtc ttcacaaata tgg 23
<210> 20
<211> 21
<212> DNA
<213> pgsB-yanR
<400> 20
gcgaacataa ggacaaaaac g 21
<210> 21
<211> 40
<212> DNA
<213> bpr-AF
<400> 21
caacgcacct ttcagcagca agcagtaaag tcacctcacc 40
<210> 22
<211> 44
<212> DNA
<213> bpr-AR
<400> 22
ggattgtcca gtgttaattc aggcattcca caccgtcagt tgct 44
<210> 23
<211> 44
<212> DNA
<213> bpr-BF
<400> 23
agcaactgac ggtgtggaat gcctgaatta acactggaca atcc 44
<210> 24
<211> 42
<212> DNA
<213> bpr-BR
<400> 24
gtaaaggata aaacagcact catctcggac gatcacttct ac 42
<210> 25
<211> 23
<212> DNA
<213> bpr-yanF
<400> 25
ggaaaaaaac gaaaaacaga ctc 23
<210> 26
<211> 23
<212> DNA
<213> bpr-yanR
<400> 26
catattaagt tttccattcg cag 23
<210> 27
<211> 40
<212> DNA
<213> mpr-AF
<400> 27
caacgcacct ttcagcagct ggtgacgcaa aatttgtcag 40
<210> 28
<211> 47
<212> DNA
<213> mpr-AR
<400> 28
ccaagttata tgacgatcct ccgccaaaca caaaaccgtt aagtaag 47
<210> 29
<211> 47
<212> DNA
<213> mpr-BF
<400> 29
cttacttaac ggttttgtgt ttggcggagg atcgtcatat aacttgg 47
<210> 30
<211> 43
<212> DNA
<213> mpr-BR
<400> 30
gtaaaggata aaacagcacc cagtatatag tttggtttcc tgc 43
<210> 31
<211> 24
<212> DNA
<213> mpr-yanF
<400> 31
tgacagagca gcaaatagaa gaag 24
<210> 32
<211> 24
<212> DNA
<213> mpr-yanR
<400> 32
gtatcatctt cttctttttc ctcc 24
<210> 33
<211> 37
<212> DNA
<213> epr-AF
<400> 33
caacgcacct ttcagcacga taggcgatcc caaaagc 37
<210> 34
<211> 48
<212> DNA
<213> epr-AR
<400> 34
ggttactttt tcggtttgac ggcagagtga ctgatacaac aagtttgc 48
<210> 35
<211> 48
<212> DNA
<213> epr-BF
<400> 35
gcaaacttgt tgtatcagtc actctgccgt caaaccgaaa aagtaacc 48
<210> 36
<211> 42
<212> DNA
<213> epr-BR
<400> 36
gtaaaggata aaacagcacc ctttacatca aaacgaagac gg 42
<210> 37
<211> 21
<212> DNA
<213> epr-yanF
<400> 37
gccccctacc atgatggact c 21
<210> 38
<211> 24
<212> DNA
<213> epr-yanR
<400> 38
ggtctcccat acatgaacga cttc 24
<210> 39
<211> 38
<212> DNA
<213> vpr-AF
<400> 39
caacgcacct ttcagcacat ccctccgctt ctttttgg 38
<210> 40
<211> 46
<212> DNA
<213> vpr-AR
<400> 40
gaaaggttct tcggtcaaaa ccgatcccct ttttcaatgt gtttcc 46
<210> 41
<211> 46
<212> DNA
<213> vpr-BF
<400> 41
ggaaacacat tgaaaaaggg gatcggtttt gaccgaagaa cctttc 46
<210> 42
<211> 43
<212> DNA
<213> vpr-BR
<400> 42
gtaaaggata aaacagcacg gctatatgtt tgcccatttt atc 43
<210> 43
<211> 22
<212> DNA
<213> vpr-yanF
<400> 43
cgcctttctt tggtatgtac gc 22
<210> 44
<211> 21
<212> DNA
<213> vpr-yanR
<400> 44
gttttccgaa tctgaccgct g 21
<210> 45
<211> 42
<212> DNA
<213> wprA-AF
<400> 45
caacgcacct ttcagcatac atattacgac atgggtggta gc 42
<210> 46
<211> 45
<212> DNA
<213> wprA-AR
<400> 46
gtatccacag ccgtgacgta cagctgcgtt tcatgttatc cctcc 45
<210> 47
<211> 45
<212> DNA
<213> wprA-BF
<400> 47
ggagggataa catgaaacgc agctgtacgt cacggctgtg gatac 45
<210> 48
<211> 41
<212> DNA
<213> wprA-BR
<400> 48
gtaaaggata aaacagcacg tctccaacac agcccaatct g 41
<210> 49
<211> 20
<212> DNA
<213> wprA-yanF
<400> 49
gctgaataaa actggagggc 20
<210> 50
<211> 20
<212> DNA
<213> wprA-yanR
<400> 50
cgtcttcaat gaggatggtg 20
<210> 51
<211> 40
<212> DNA
<213> aprX-AF
<400> 51
caacgcacct ttcagcagga gggttttagt aacaggctgc 40
<210> 52
<211> 43
<212> DNA
<213> aprX-AR
<400> 52
cggaattttc tgcgttgaca ggtaacggcc aatctagctt gtg 43
<210> 53
<211> 43
<212> DNA
<213> aprX-BF
<400> 53
cacaagctag attggccgtt acctgtcaac gcagaaaatt ccg 43
<210> 54
<211> 40
<212> DNA
<213> aprX-BR
<400> 54
gtaaaggata aaacagcacc ttcagcccac tcaacctgag 40
<210> 55
<211> 24
<212> DNA
<213> aprX-yanF
<400> 55
gattgtcacg gttattagcg gttc 24
<210> 56
<211> 22
<212> DNA
<213> aprX-yanR
<400> 56
ccagtcggta aaggtccagt cc 22
Claims (3)
1.一种高效表达纤溶酶的枯草芽孢杆菌工程菌，其特征在于：它是通过将枯草芽孢杆菌进行基因敲除后获得；所敲除的基因包括芽孢形成编码基因spo0A，淀粉酶编码基因amyE，部分蛋白酶编码基因bpr、mpr、epr、vpr、wprA、aprX，聚谷氨酸合酶编码基因pgsB。
2.根据权利要求1所述高效表达纤溶酶的枯草芽孢杆菌工程菌，其特征在于：所述枯草芽孢杆菌为枯草芽孢杆菌枯草亚种，其保藏编号为CICC 20637。
3.权利要求1或2所述高效表达纤溶酶的枯草芽孢杆菌工程菌的制备方法，包括如下步骤：
1)根据目标基因上下游同源臂序列设计敲除引物，引物末端和载体末端具有15～20个同源碱基；
2)PCR扩增：提取枯草芽孢杆菌总DNA，以其作为模板，用各基因对应的上、下游同源臂引物进行PCR扩增，得到目的同源臂DNA片段；
3)通过SOE-PCR分别将各基因的上下游同源臂连接起来，得到9个基因敲除片段；
4)通过无缝克隆将基因敲除片段连接到敲除载体上，得到对应的9个目标基因敲除载体；
5)枯草芽孢杆菌的遗传转化，对枯草芽孢杆菌感受态的制备及利用1个目标基因敲除载体进行电转化；
6)通过抗性筛选和PCR扩增对转化子进行验证；
7)挑选阳性转化子进行传代，经过高温传代，质粒消除，点种和PCR验证后，筛选出目标基因敲除菌株；
8)在得到目标基因敲除菌株后，以其为出发菌株，重复步骤5)～7)用同样的方法对下一个目标基因进行敲除，直至得到敲除9个基因的目标菌种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810140886.8A CN108410786B (zh) | 2018-02-09 | 2018-02-09 | 高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810140886.8A CN108410786B (zh) | 2018-02-09 | 2018-02-09 | 高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108410786A true CN108410786A (zh) | 2018-08-17 |
| CN108410786B CN108410786B (zh) | 2021-10-15 |
Family
ID=63128467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810140886.8A Active CN108410786B (zh) | 2018-02-09 | 2018-02-09 | 高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108410786B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109055272A (zh) * | 2018-09-07 | 2018-12-21 | 安徽瑞邦生物科技有限公司 | 一种高密度培养枯草芽孢杆菌的方法 |
| CN114891771A (zh) * | 2022-06-28 | 2022-08-12 | 湖北真福医药有限公司 | 一种保护血管内皮的组合物及其制备方法和应用 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102181469A (zh) * | 2011-03-21 | 2011-09-14 | 江苏大学 | 枯草芽孢杆菌表面展示人血清白蛋白重组芽孢及其制备方法 |
| CN104073458A (zh) * | 2013-03-26 | 2014-10-01 | 南京金斯瑞生物科技有限公司 | 一株可高效表达外源分泌蛋白酶的枯草芽孢杆菌 |
| CN105368762A (zh) * | 2014-08-24 | 2016-03-02 | 武汉骏安生物科技有限公司 | 一株可以高效分泌纳豆激酶的地衣芽胞杆菌工程菌 |
| CN106085934A (zh) * | 2016-06-12 | 2016-11-09 | 武汉康复得生物科技股份有限公司 | 食品级纳豆激酶表达菌 |
| CN106893736A (zh) * | 2017-01-24 | 2017-06-27 | 湖北大学 | 一种提高地衣芽胞杆菌外源蛋白分泌水平的方法 |
| CN107083375A (zh) * | 2017-06-02 | 2017-08-22 | 北京科为博生物科技有限公司 | 一种中温α‑淀粉酶及其基因和应用 |
-
2018
- 2018-02-09 CN CN201810140886.8A patent/CN108410786B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102181469A (zh) * | 2011-03-21 | 2011-09-14 | 江苏大学 | 枯草芽孢杆菌表面展示人血清白蛋白重组芽孢及其制备方法 |
| CN104073458A (zh) * | 2013-03-26 | 2014-10-01 | 南京金斯瑞生物科技有限公司 | 一株可高效表达外源分泌蛋白酶的枯草芽孢杆菌 |
| CN105368762A (zh) * | 2014-08-24 | 2016-03-02 | 武汉骏安生物科技有限公司 | 一株可以高效分泌纳豆激酶的地衣芽胞杆菌工程菌 |
| CN106085934A (zh) * | 2016-06-12 | 2016-11-09 | 武汉康复得生物科技股份有限公司 | 食品级纳豆激酶表达菌 |
| CN106893736A (zh) * | 2017-01-24 | 2017-06-27 | 湖北大学 | 一种提高地衣芽胞杆菌外源蛋白分泌水平的方法 |
| CN107083375A (zh) * | 2017-06-02 | 2017-08-22 | 北京科为博生物科技有限公司 | 一种中温α‑淀粉酶及其基因和应用 |
Non-Patent Citations (2)
| Title |
|---|
| 吴燕等: "纳豆激酶液态发酵生产的研究进展", 《食品与发酵工业》 * |
| 张明俐等: "无痕敲除法构建食品安全级枯草芽孢杆菌无芽孢菌株", 《生物工程》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109055272A (zh) * | 2018-09-07 | 2018-12-21 | 安徽瑞邦生物科技有限公司 | 一种高密度培养枯草芽孢杆菌的方法 |
| CN114891771A (zh) * | 2022-06-28 | 2022-08-12 | 湖北真福医药有限公司 | 一种保护血管内皮的组合物及其制备方法和应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108410786B (zh) | 2021-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ghani et al. | Isolation and characterization of different strains of Bacillus licheniformis for the production of commercially significant enzymes | |
| CN103937830B (zh) | 一种高效分泌表达纳豆激酶的重组菌 | |
| CN112522173B (zh) | 一种生产异源碱性蛋白酶的工程菌及其构建方法 | |
| Ghasemi et al. | Cloning of a fibrinolytic enzyme (subtilisin) gene from Bacillus subtilis in Escherichia coli | |
| US11655464B2 (en) | Alkaline protease mutant, and gene, engineered strain, preparation method and application thereof | |
| Jeong et al. | Cloning and characterization of a novel intracellular serine protease (IspK) from Bacillus megaterium with a potential additive for detergents | |
| CN110777089B (zh) | 一株高产纳豆激酶的菌株及利用该菌株制备纳豆的方法 | |
| CN112458072B (zh) | 一种碱性蛋白酶突变体及其制备 | |
| CN109593746A (zh) | 一种催化性能提高的角蛋白酶突变体及应用 | |
| CN108410786A (zh) | 高效表达纤溶酶的枯草芽孢杆菌工程菌以及制备方法 | |
| CN113699138B (zh) | 碱性蛋白酶基因、杂合启动子、重组表达载体、重组表达工程菌、碱性蛋白酶及方法和应用 | |
| CN111153968A (zh) | 一种提高外源碱性蛋白酶表达量的信号肽突变体及其构建方法与用途 | |
| CN104450632B (zh) | 一组可提高sod耐热温度和热稳定性的氨基酸序列及其应用 | |
| CN110106128B (zh) | 一种生产重组碱性蛋白酶的基因工程菌及其构建方法 | |
| CN110144319B (zh) | 高效异源表达碱性蛋白酶的基因工程菌及其构建方法 | |
| CN103103205B (zh) | 编码重组猪圆环病毒2型Cap蛋白的基因及其应用 | |
| CN115851679B (zh) | 一种低温高活力碱性蛋白酶突变体及其应用 | |
| Zhang et al. | Expression, purification, and characterization of a thermophilic neutral protease from Bacillus stearothermophilus in Bacillus subtilis | |
| CN116286565B (zh) | 一株高产碱性蛋白酶的枯草芽孢杆菌菌株及其应用 | |
| CN113005045B (zh) | 一株含突变纳豆激酶重组基因的工程菌及其构建方法和应用 | |
| CN104152429A (zh) | 纳豆激酶高产枯草芽孢杆菌株的筛选及液态发酵的方法 | |
| CN104928308A (zh) | 溶栓酶基因及含有该基因的重组表达载体、重组菌以及应用 | |
| CN105420220A (zh) | 一种天冬氨酸类蛋白酶及其编码基因与应用 | |
| Etienne et al. | New Phylogenetic Molecular Markers in Bacteria of the Genus Bacillus: Fibrinolytic Proteases | |
| CN113801831B (zh) | 一株高产中性蛋白酶的枯草芽孢杆菌及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220118 Address after: 430075 floor 5, unit 1, building 17, Wuhan Optical Valley International Biomedical enterprise accelerator, No. 388, Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee after: WUHAN ZHENFU PHARMACEUTICAL Co.,Ltd. Address before: 430075 building B1, R & D building, zone B, C and D, Wuhan biological industry base project, 666 Gaoxin Avenue, Donghu hi tech Development Zone, Wuhan City, Hubei Province Patentee before: WUHAN REFINE MEDICAL DEVICES CO.,LTD. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240102 Address after: Buildings 1, 2, and 4, Phase I of Donghu High tech Smart City, No. 216 Jianshe Avenue, Gedian Development Zone, Ezhou City, Hubei Province, 436070 Patentee after: Hubei Zhen Fu Pharmaceutical Co.,Ltd. Address before: 430075 floor 5, unit 1, building 17, Wuhan Optical Valley International Biomedical enterprise accelerator, No. 388, Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee before: WUHAN ZHENFU PHARMACEUTICAL Co.,Ltd. |
|
| TR01 | Transfer of patent right |